Background: Rising out-of-pocket costs are creating a need for cost conversations between patients and physicians.
D
ecades ago, avoiding cost conversations made sense, because patients with insurance were shielded from the majority of their health care expenses and those without insurance often received charity care while the costs were shifted to third-party payers (1) . For physicians, bringing up costs in the face of treatment decisions created a dilemma. The medical needs of the patients may supersede their ability to afford needed treatments (2) , and physicians are probably unaware of the costs (3). Now, patients are responsible for increasingly high outof-pocket costs: High-deductible health care plans are more common, and use of expensive interventions had increased (4 -8) . Rising out-of-pocket costs have resulted in an upward trend of insured individuals reporting difficulty affording medical costs (9) . This trend corresponds with rising premiums, deductibles, and other types of cost-sharing (10).
Physicians must engage in cost conversations with their patients to help manage their out-of-pocket costs. Patients are struggling and making sacrifices in other aspects of their lives to afford their health care (4) . Among the 29% of Americans who reported problems paying medical bills, 73% are cutting back on spending on food, clothing, or basic household items (10). Among those who may not have had difficulty affording care or paying bills, one half still worry about their ability to afford needed health care services (10). Challenges with affording care results in individuals postponing care, skipping recommended treatments, and not filling prescriptions (9) . When cost is not considered in a treatment plan, patients are left to figure out how to sort through and choose from costly prescriptions, treatments, and tests.
How physicians address cost of care is poorly understood (11) . Studies of the frequency of cost conversations vary substantially (12) , which is probably attributable to a majority of studies reporting on specific regions (3, 13) , specialties (14, 15) , patient populations (16, 17) , or conditions or diseases (12, 18, 19) .
A better understanding of how out-of-pocket costs influence physicians' treatment decisions and the factors that influence them to initiate a cost conversation could assist in developing interventions to promote 
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Web-Only Visual Abstract Supplement cost conversations between patients and physicians. Determining health care costs should help elucidate the prompts providers need to initiate a cost conversation. To explore these issues, we used a mixed-methods instrument design model (20).
METHODS

Study Design
The study involved 2 phases: qualitative one-onone interviews and a quantitative survey. The Institutional Review Board of California State University, Sacramento, approved this research as exempt.
Qualitative Interviews
One of the authors (S.L.P.) conducted the semistructured telephone interviews with internal medicine physicians across the United States. The participants and the interviewer did not have any contact before the interview. Participants were informed that they were going to participate in a 1-hour interview about their experience discussing costs with patients.
The facilitator's guide was developed in consultation with 2 clinicians, 2 health consumer advocates, and a health services researcher. The facilitator's guide inquired about physician workload (not reported in this article) and incorporated themes and common experiences shared from patient focus groups (Supplement 1, available at Annals.org). Information was collected about participant specialty, as well as length of time practicing overall and in their current setting.
Using a third-party recruitment firm (KeyQuest Health), physician participants were selected from a na- "Oh yeah, they will delay their visits. For a 6-month follow-up, they might cancel and make it for 7 months-try to stretch it out a bit, so they're not in twice a year, but maybe 3 times every 2 years. That's just the way it is." Patient is not improving "I'll see the patient back in a few months, and their diabetes is under poor control, but they don't tell me anything. And so, I'll call them a couple of days later, and say, you know, your numbers come back, and your diabetes isn't doing well. I'm surprised that the medicines I put you on aren't helping. And at that point, and only at that point, the patient says, 'well, I haven't been taking those new medicines because I couldn't afford them.' So, you've wasted months and months and months, and several office visits, just to find out the patient couldn't afford the medicines." Patient discusses financial struggles "I mean, if patients come in and they tell me as part of our discussion that they're on a lot of medicines, and they only get so much money from Social Security, and they've paid so much money for their health insurance amount, then I'm starting to get the idea that cost is an issue. But you know, nothing beats just coming out and saying it."
Addressing cost sensitivity with a treatment plan Discussing potential costs "I'm straight with patients. And I tell them, your insurance company-before they're going to approve an MRI, you're going to have to have x-ray and/or a CT scan first just so I can guide them to the practice. And so they don't think that I'm not as thorough as I want to be by just doing an MRI first and foremost, since insurance doesn't really allow that in most cases." Treatment alternatives "There's really rarely a situation where we cannot find a cheaper alternative. There are a few drug classes where you just don't have anywhere to go. But they're not critical medications such that there's really no reason why someone couldn't have all of their medical conditions controlled with medications priced reasonably. And that's assuming they're willing to take generic, of course, but the generics have really come down so significantly in price. They're very affordable, even if you're taking multiple medications." Treatment trade offs "They'll ask me [about] side effects of the medicine. And I'll say, hey, the side effect of this medicine is going to be cost. I'll even list it as a side effect. And then all of a sudden, the one good news about this thing is it's not going to cost-or at least the good news is [that] it should be generic and it should be manageable. Oh, I could go on and on. It's a big issue." * Quotations have been lightly edited for clarity and flow.
tional database of internal medicine physicians. Individuals were invited for an interview if their practice was in the United States and consisted of at least 50% time (0.5 full-time equivalent) seeing patients in an outpatient setting. Telephone interviews were conducted in September 2017.
Interviews were audio-recorded, transcribed verbatim, and coded. During data collection, 2 authors (S.L.P. and L.C.) met every 2 days to debrief and compare notes from the review of transcripts. The development of themes emerging from the qualitative data was in theory guided by the constant comparison method: immersion in the transcripts (reading and rereading), development of themes and codes, coding the transcripts, and reintegrating the codes into an explanatory narrative (21) . Disagreements were resolved through consultation and discussion with a third team member (D.P.) until the team reached consensus.
Transcripts were analyzed with a grounded theory approach in which codes, categories, and themes that emerged from the data were identified by using the ATLAS software. After the initial reading of all transcripts, 2 authors (S.L.P. and L.C.) developed codes based on the interview protocol and research questions. Continuous thematic cross-checking contributed to the reliability of the qualitative coding. The research team established that recruitment and data collection would be complete once theoretical saturation was reached. Theoretical saturation occurred when the team agreed upon categories, the properties of those categories, and there is enough evidence to saturate those categories (22) .
Quantitative Survey
The survey instrument was developed on the basis of a literature review and the qualitative interviews. With the assistance of a medical librarian, 2 electronic databases (SCOPUS and the Health and Psychosocial Instruments) were used to search for validated instruments on cost conversations from the perspective of physicians, using the Medical Subject Heading terms "cost" AND "communication" and "physicians" and "validated." Only English-language articles from the United States were included.
Items were developed by using constructs from cost conversation survey instruments and the qualitative interviews. Key constructs resulting from the qualitative findings for item development included 1) recognizing when a cost conversation is needed, 2) acknowledging that patients might be hesitant to discuss the cost of care, 3) anticipating high out-of-pocket costs, and 4) willingness to provide treatment options that are equally as effective and affordable. The research team reviewed the items and eliminated redundant items. An expert panel consisting of physicians, health services researchers, and consumer advocates reviewed, revised, and selected the final items for inclusion. The survey items (Supplement 2, available at Annals.org) were developed by using themes that emerged from the interviews. Information was collected about participant specialty; location of patient care (outpatient versus inpatient); percentage of time spent in direct patient care; geographic region of practice; and type of patient demographic served, using insurance as a proxy for socioeconomic status (for example, percentage of patients relying on public insurance programs) and age.
The survey was piloted by administering it to 221 American College of Physicians (ACP) members. During the pilot phase, respondents were asked to comment on the questions. Analysis of the pilot survey findings resulted in shortening the survey by eliminating questions, rearranging the survey to keep items that dealt with similar topics together, and adding further options to survey items on the basis of open-ended responses.
A sample of 3000 ACP members was randomly selected to participate in a Web-based survey about costs of care. Members of the ACP are internal medicine physicians specializing in general internal medicine or an internal medicine subspecialty. Members were included in the sample selection if they were a U.S. resident with a valid e-mail address who allowed ACP to contact them for research purposes and who had not been selected to participate in other ACP surveys. Eli- 
Descriptive statistics were used to analyze survey data. For questions reporting frequency, responses of "always" and "most of the time" were combined and reported as "frequently," and responses of "sometimes," "rarely," and "never" were combined and reported as "less frequently." For questions reporting importance, responses of "extremely important" and "moderately important" were combined and reported as "very important," and responses of "somewhat important," "rarely important," and "not at all important" were combined and reported as "less important."
Role of the Funding Source
This study was funded by the Robert Wood Johnson Foundation. The funding source played no role in the design, conduct, or reporting of the study.
RESULTS
Qualitative Interviews
Of the 38 individuals contacted, 20 met eligibility criteria and consented to interview. All participants were internal medicine physicians currently practicing within the 50 U.S. states who spent greater than 70% of their time working in outpatient clinics. Two participants reported having a subspecialty: one in cardiology and the other in geriatrics. The average length of time practicing medicine was 22.83 years (range, 14 to 32 years). The average length of time practicing in their current practice was 21.25 years (range, 15 to 28 years). Participants served a mix of insurance types: Medicare, privately or employer-insured, and uninsured.
Interview Themes
Participants acknowledged that some patients struggling to afford their medical costs might be hesitant to bring up costs, because of embarrassment or the patient's unwillingness to question their doctor owing to their hierarchical perspective of health care. Therefore, participants reported relying on clues about a patient's inability to afford their health care, such as a patient not adhering to recommended care, delaying care, not improving, or talking about financial struggles ( Table 1) . Whereas participants reported rarely knowing the exact out-of-pocket costs for their patients, they reported being able to offer general explanations of potential costs or walk patients through processes to help get medications, treatments, and services covered or more affordable. They reported pairing this discussion with a conversation about potential alternatives, if available. Participants were aware that some patients must make difficult financial tradeoffs when developing a treatment plan that includes a new prescription, test, or treatment.
Survey Response
Of the 16 484 ACP members who were eligible to be included in the sample, 3000 physicians were randomly selected to receive the survey by e-mail. Seventythree respondents were eliminated on the basis of survey responses that did not meet the inclusion criteria, and 621 individuals who provided responses were therefore included in the study (21% of 2927 eligible physicians). Respondent characteristics are reported in Table 2 . Responders were compared with nonresponders across a variety of demographic indicators collected previously by ACP. Responders and nonresponders did not differ in terms of age, race, subspecialty, professional activity, or geographic region. Participant characteristics were similar to the ACP membership characteristics ( Table 2) .
Almost all participants who reported having frequent discussions about patients' out-of-pocket treatment costs indicated that they were aware of patients going without medical care because of the cost (95% [n = 275]), compared with 86% (n = 244) of those who reported having less frequent discussions. Among the participants who had more frequent discussions about patients' out-of-pocket treatment costs, the majority stated that the cost to the patient (66% [n = 199]) and patient's insurance coverage (73% [n = 220]) are very important factors in their decision to order a particular medical test. Of those who had less frequent discussions about patients' out-of-pocket treatment costs, 49% (n = 156) reported cost to the patient and 64% (n = 202) reported the patient's insurance coverage as important factors in their decision to order a particular medical test. Almost all participants who reported having frequent discussions with patients about cost stated that they considered cost to the patient when making clinical decisions (95% [n = 297] vs. 56% [n = 179] of those having less frequent discussions about cost).
Whereas 75% (n = 466) of participants reported frequently considering out-of-pocket costs when making clinical decisions, only 50% (n = 303) reported having frequent discussions about these costs on a daily basis with their patients. Most participants who had frequent cost conversations were aware of patients having taken smaller or less doses of medication owing to the cost (94% [n = 260] vs. 84% [n = 218] of those who had less frequent discussions). Among the participants who reported frequent cost conversations, 24% (n = 74) reported a time in the past 12 months when they wanted to discuss out-of-pocket drug costs with a patient but did not do so, compared with 37% (n = 117) of those not having frequent cost conversations. Slightly more than one half (55% [n = 202]) of the participants who reported frequently considering cost when making clinical decisions indicated that ordering a test is easier than explaining the cost to a patient, versus two thirds (66% [n = 81]) of participants who reported considering cost less frequently.
Three quarters (77% [n = 478]) of participants reported that in the past 12 months, there was a time when any of their patients took medicine in smaller doses or less frequently than prescribed because of the cost. Almost every participant who reported having any patients who had taken smaller doses in the past 12 months also reported having patients who did not fill a prescription for medicine because of the cost (99% [n = 469]). This compares with 62% (n = 36) of physicians who reported having no patients taking smaller doses and not filling a prescription owing to the cost.
Nine in 10 participants (89% [n = 555]) reported that during the past 12 months, there was a time when any of their patients did not fill a prescription for medicine because of the cost. Most participants who reported frequently considering patients' out-of-pocket costs were aware of patients who had not filled a prescription (96% [n = 423] vs. 91% [n = 132] of participants who reported considering these costs less frequently) or had taken smaller or less frequent doses of medication (90% [n = 377] vs. 84% [n = 101]) owing to the cost.
A majority of participants (84% [n = 519]) reported having knowledge that any of their patients went without medical care in the past year because they could not afford the tests, treatments, or follow-up care. Of participants who reported that their patients went without medical care because of the cost, 46% (n = 236) were older than 55 years (compared with 71% [n = 39] of other participants), and 47% (n = 234) stated that commercial insurance covers a majority of their patients (compared with 29% [n = 5] of other participants).
For 31% (n = 191) of participants, there were times in the past year when they wanted to discuss out-ofpocket prescription drug costs with patients but did not do so. This did not vary by participant subspecialty, age, region, insurance coverage, or whether a participant reported having any patients who did not fill a prescription or take smaller or less frequent doses owing to cost. Among the participants who report frequent cost conversations, 7 in 10 (69% [n = 210]) stated that cost to the patient is the most important factor when deciding which drugs to prescribe, compared with 56% (n = 178) of participants who did not report having frequent cost conversations.
Of participants who reported frequently considering patients' out-of-pocket costs, 28% (n = 132) indicated there were times when they wanted to discuss drug costs with a patient but did not do so (compared with 38% [n = 59] of those who did not frequently consider these costs), and 69% (n = 323) reported cost as the most important factor when deciding to prescribe a drug to the patient (compared with 42% [n = 65]).
Most participants who reported frequently considering costs when making clinical decisions were aware of patients under their care going without a test, treatment, or follow-up because they could not afford it (92% [n = 404] vs. 84% [n = 115] of those who considered these costs less frequently). Furthermore, the majority of these participants stated that cost (66% [n = 308] vs. 30% [n = 47] of other participants) and insurance coverage for the test (74% [n = 344] vs. 50% [n = 78] of other participants) are very important factors when deciding to order a medical test.
Beyond efficacy and side effects, cost is the most important factor in the decision of which drug to prescribe. Participants ranked the importance of 4 factors in their decision of which drugs to prescribe to patients. Almost two thirds reported that cost to the patient is the most important factor in their decision; second most important was whether the drug is on the formulary list; and third was the cost to the health care system. The least important factor according to participants was whether the patient requests the drug ( Table 3) .
Participants who ranked cost to the patient as being most important in their decision of which prescription drug to prescribe differed from the other participants in several ways. Almost one half (48% [n = 179]) of these participants reported Medicare as covering the majority of their patients (compared with 40% [n = 90] who did not rank cost to the patient as the most important factor), and 8% (n = 29) reported coverage by Beyond the evidence of the test, participants were asked to rate the importance of 6 factors in their decision to order a particular medical test. The most influential factors appeared to be the desire to be as thorough as possible and insurance coverage for the test. This was followed by cost of the test and fear of missing something. The least important factors according to participants were a colleague's recommendation and a patient's request ( Table 4 
DISCUSSION
Our qualitative data suggest that physicians are aware of the burden of health care costs and are willing to outline alternative options based on a patient's cost sensitivity. However, the cost burden to patients may not be recognizable during clinical encounters. Participants reported using such clues as patients not following through on treatments or tests to identify patients with cost concerns. Yet such clues may not be present if patients are making sacrifices in other aspects of their lives in order to meet medical expenses. Although both our qualitative and survey results indicate that most participating physicians recognize the importance of health care costs, not all are routinely discussing costs with their patients.
Lack of transparency of health care costs was cited by study participants as a barrier to engaging in cost conversations. However, although transparent information on costs enable informed cost conversations, not knowing precise costs does not prevent including cost concerns in conversations about treatment decisions.
A strength of this study was the integration of quantitative and qualitative methods. This enabled us to capture detailed information about participating physicians' behaviors and attitudes about discussing costs of care with patients.
The study also has limitations. First, we studied only U.S. internal medicine physicians who were members of a single professional organization. In addition, the survey response rate was less than 25%, and the survey was not validated for its accuracy in reflecting actual physician behaviors.
In summary, internal medicine physicians seem to be aware of the importance of cost-of-care concerns and recognize that patients are often hesitant or unwilling to initiate a cost conversation. However, there are barriers to having cost conversations; these include the difficulty of obtaining accurate information about patient's out-of-pocket costs and time constraints. Further research is needed to understand how to incorporate cost conversations into clinical interactions and to explore the impact of these conversations on medical decision making and patient outcomes. 
